New 52 Week Low Today

Bristol-Myers Squibb Co BMY:NYSE

RT Quote | Last NASDAQ LS, VOL From CTA | USD

After Hours: Last | 04/26/24 EDT

44.88

+0.03 (+0.07%)

Volume

1,578,464

44.85

+0.15 (+0.34%)

Volume

19,629,599

52 week range

44.34 - 69.74

Open44.68
Day High45.37
Day Low44.34
Prev Close44.70
52 Week High69.74
52 Week High Date04/26/23
52 Week Low44.34
52 Week Low Date04/26/24

Key Stats

Market Cap90.90B
Shares Out2.03B
10 Day Average Volume14.75M
Dividend2.40
Dividend Yield5.35%
Beta0.44
YTD % Change-12.59

KEY STATS

Open44.68
Day High45.37
Day Low44.34
Prev Close44.70
52 Week High69.74
52 Week High Date04/26/23
52 Week Low44.34
52 Week Low Date04/26/24
Market Cap90.90B
Shares Out2.03B
10 Day Average Volume14.75M
Dividend2.40
Dividend Yield5.35%
Beta0.44
YTD % Change-12.59

RATIOS/PROFITABILITY

EPS (TTM)-3.10
P/E (TTM)-14.45
Fwd P/E (NTM)75.00
EBITDA (TTM)20.625B
ROE (TTM)26.53%
Revenue (TTM)45.006B
Gross Margin (TTM)76.44%
Net Margin (TTM)17.86%
Debt To Equity (MRQ)135.14%

EVENTS

Earnings Date07/26/2024(est)
Ex Div Date04/04/2024
Div Amount0.60
Split Date-
Split Factor-

Latest On Bristol-Myers Squibb Co

Bristol Myers Squibb beats on revenue, launches $1.5 billion cost cuts as it posts quarterly lossApril 25, 2024CNBC.com
It’s the busiest week in earnings and these stocks could see a blow upApril 24, 2024CNBC.com
5 things to know before the stock market opens MondayApril 22, 2024CNBC.com
These are the 10 most overvalued stocks in the S&P 500April 18, 2024CNBC.com
These are the top 5 companies to work for in India, according to LinkedInApril 15, 2024CNBC.com

Content From Our Affiliates

Bristol Myers price target lowered to $55 from $60 at BofAApril 26, 2024TipRanks
Bristol Myers announces EMA’s CHMP recommended approval of OpdivoApril 26, 2024TipRanks
Analysts Offer Insights on Healthcare Companies: Universal Health (UHS), Laboratory (LH) and Bristol-Myers Squibb (BMY)April 26, 2024TipRanks
Bristol-Myers Squibb: Hold Rating Amid Mixed Performance and Future Revenue ConcernsApril 26, 2024TipRanks
Bristol Myers price target lowered to $43 from $51 at BarclaysApril 26, 2024TipRanks

Profile

Bristol-Myers Squibb Company is a biopharmaceutical company engaged in the discovery, development and delivering advanced medicines that help patients prevail over serious diseases. It offers products for various therapeutic classes, which includes oncology, hematology, immunology, cardiovascular and neuroscience. Its pharmaceutical products include chemically synthesized or small molecule drugs, products produced from biological processes, called biologics and chimeric...

Christopher Boerner Ph.D.

Chairman of the Board, Chief Executive Officer, Chief Operating Officer

David Elkins

Executive Vice President, Chief Financial Officer, Member of the Leadership Team

Cari Gallman

Executive Vice President, Corporate Affairs, Member of the Leadership Team

Sandra Leung

Executive Vice President, General Counsel, Member of the Leadership Team

Adam Lenkowsky

Executive Vice President, Chief Commercialization Officer, Member of the Leadership Team

Address

Route 206 And Province Line Road

Princeton, NJ

08543

United States

https://www.bms.com/

Top Peers

SYMBOL	LAST	CHG	%CHG
SNY Sanofi SA	49.13	-0.23	-0.47%
GSK GSK plc	41.11	+0.20	+0.49%
GILD Gilead Sciences Inc	65.42	+0.15	+0.23%
PFE Pfizer Inc	25.40	+0.14	+0.55%
AMGN Amgen Inc	269.98	+0.60	+0.22%